Concepedia

Martha A. Warpehoski

MA

Statistics

Publications

16

Citations

1.1K

H-Index

16

Active since

1981

Affiliations

W.E. Upjohn Institute for Employment Research(Current)

Pfizer (United States)

The University of Texas at Austin

Martha A. Warpehoski is an author at W.E. Upjohn Institute for Employment Research specializing in pharmacy, medicinal chemistry, and drug discovery.

Publications per year

1981–2004

16

Publications

16

3-Aminopyrazole Inhibitors of CDK2/Cyclin A as Antitumor Agents. 1. Lead Finding

Paolo Pevarello, Maria Gabriella Brasca, Raffaella Amici et al. · Journal of Medicinal Chemistry · 2004 · 161 citations · Full text

, , +16

Molecular basis for sequence-specific DNA alkylation by CC-1065

Laurence H. Hurley, Chong Soon Lee, J. Patrick McGovren et al. · Biochemistry · 1988 · 144 citations

, , +6

Stereoelectronic factors influencing the biological activity and DNA interaction of synthetic antitumor agents modeled on CC-1065

Martha A. Warpehoski, Ilse Gebhard, Robert C. Kelly et al. · Journal of Medicinal Chemistry · 1988 · 129 citations

, , +17

Sequence specificity of DNA alkylation by the unnatural enantiomer of CC-1065 and its synthetic analogs

Laurence H. Hurley, Martha A. Warpehoski, Chong Soon Lee et al. · Journal of the American Chemical Society · 1990 · 106 citations

, , +7

Adozelesin, a selected lead among cyclopropylpyrroloindole analogs of the DNA-binding antibiotic, CC-1065

Li H. Li, Robert C. Kelly, Martha A. Warpehoski et al. · Investigational New Drugs · 1991 · 85 citations

, , +12

1–5 of 16